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Abstract: We have previously demonstrated that Phoneutria nigriventer venom (PNV) causes
blood–brain barrier (BBB) breakdown, swelling of astrocytes end-feet and fluid permeation
into brain interstitium in rats. Caveolae and water channels respond to BBB alterations by
co-participation in shear stress response and edema formation/resolution. Herein, we showed
post-natal developmental-related changes of two BBB-associated transporter proteins: the endothelial
caveolin-1 (Cav-1), the major scaffolding protein from caveolae frame, and the astroglial aquaporin-4
(AQP4), the main water channel protein expressed in astrocytic peri-vascular end-feet processes,
in the hippocampus of rats intraperitoneally-administered PNV. Western blotting protein levels;
immunohistochemistry (IHC) protein distribution in CA1, CA2, and CA3 subfields; and gene
expression by Real Time-Polymerase Chain Reaction (qPCR) were assessed in post-natal Day 14
(P14) and 8–10-week-old rats over critical periods of envenomation. The intensity and duration of
the toxic manifestations indicate P14 neonate rats more vulnerable to PNV than adults. Histologically,
the capillaries of P14 and 8–10-week-old rats treated with PNV showed perivascular edema,
while controls did not. The intensity of the toxic manifestations in P14 decreases temporally
(2 > 5 > 24 h), while inversely the expression of AQP4 and Cav-1 peaked at 24 h when clinically
PNV-treated animals do not differ from saline controls. IHC of AQP4 revealed that hippocampal
CA1 showed the least expression at 2 h when toxic manifestation was maximal. Subfield IHC
quantification revealed that in P14 rats Cav-1 peaked at 24 h when toxic manifestations were
absent, whereas in 8–10-week-old rats Cav-1 peaked at 2 h when toxic signs were highest,
and progressively attenuated such increases until 24 h, remaining though significantly above
baseline. Considering astrocyte-endothelial physical and functional interactions, we hypothesize
that age-related modulations of AQP4 and Cav-1 might be linked both to changes in functional
properties of astrocytes during post-natal development and in the BBB breakdown induced by the
venom of P. nigriventer.
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1. Introduction
Accidents involving the spider Phoneutria nigriventer are common in the Southeast of Brazil.
They are responsible for great part of the notified cases of araneism in the country; the majority
of accidents being characterized by intense local pain and edema which rarely evolves to serious
complications or death. Less than 1% of accidents are graded as severe, children being the main
victims of this category of accident [1]. The P. nigriventer venom (PNV) produces important excitatory
effects [2,3] and its mechanism of action indicates the nervous system a key target. A plethora of
neurotoxic peptides contained in the venom shows activity on Na+, K+ and Ca2+ channels and chemical
receptors of excitable membranes of insects and mammals ([4,5], see [6] for review). It is known
that altered homeostasis in ion movements in the nervous tissue compartments underlies neuronal
dysfunction and a number of pathologies of the nervous system. Thereupon, a great therapeutic
interest motivates the abundant number of physiological and pharmacological studies involving PNV
aiming at the development of new drugs [6,7].
An important feature of PNV that has been consistently detected since the very first work by
Le Sueur et al. [8] is its ability to disrupt the blood–brain barrier (BBB) in the hippocampus of rats.
Apart from breaking down the paracellular barrier [7], PNV also disturbs the steady-state of the
transcellular route by a microtubule-mediated transendothelial vesicular transport [9]. In addition
to BBB disruption, PNV induces cytotoxic edema of perivascular astrocytes end-feet and vasogenic
edema within neuropil interstitium in hippocampus [8] and cerebellum [10,11].
More recently, two proteins involved in transport mechanisms were shown to be upregulated in
the cerebellum of animals administered with PNV, aquaporin-4 (AQP4) and caveolin-1 (Cav-1) [12–14].
AQP4 is one of the key players in edema formation and resolution [15]; it belongs to a family of
integral transmembrane water channel proteins, which regulates the rapid transport of water within
the perivascular astrocyte end-feet [16,17] thus permitting water selective bidirectional movement
in response to osmotic gradient, without expenditure of energy (ATP) [18,19]. Cav-1 is the main
structural protein of caveolae, dynamic cell structures that play role in endocytosis and trafficking
via fluid-phase transcytosis [20]; Caveolae/caveolin-1 system also participates in lipid homeostasis,
cellular/synaptic signaling [21–24]. Cav-1 is the most known protein of the caveolin family, being its
α isoform more abundant in brain vessels [25]. In the brain, the increases in Cav-1 and endothelial
caveolae induced by PNV [13,14] have been associated with BBB and pathologies of brain edema
involving aquaporins [26,27].
The present study has been designed to investigate whether PNV affects two specific markers
of key cells that form the BBB: the AQP4 of astrocytes and Cav-1 of endothelium. The investigation
was carried out in the hippocampus of rats at different postnatal developmental stages, postnatal day
fourteenth rats (P14) and 8–10 week-old rats. Time-course changes in AQP4 and Cav-1 expressions
in the hippocampus were selected according to the clinical evolution of animals after envenomation:
severe envenomation state (2 h), signs of amelioration of the clinical condition (5 h), and absence of
signs of envenomation (24 h).
2. Results
The chronology of the clinical signs and symptoms of animals resulting from PNV injection
followed the already described manifestations [8,10]. Soon after envenomation, the animals exhibited
severe toxicity which was characterized by piloerection, hyper salivation, intense redness of the ears,
paralyses of hind limbs, respiratory distress and stayed motionless at the cage corner; 5 h after PNV
exposure, the animals started showing some signs of amelioration of their toxic condition; and 24 h
after envenomation, the animals behavior were not different from the exhibited by the saline-treated
animals. The severity of symptoms was more precocious and recovery delayed in P14 than in adult rats.
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2.1. Western Blotting (WB) and Real Time-Polymerase Chain Reaction (qPCR)
These assays were employed to determine the levels of AQP4 and Cav-1 proteins and respective
mRNA transcripts in hippocampi of saline- and PNV-administered rats (Figure 1). In P14 neonate
PNV-treated group, the expression of AQP4 showed a tendency to decrease followed by significant
increase above baseline at 24 h (Figure 1A,B) (p < 0.05); AQP4 mRNA decreased at 2 and 5 h followed
by recovery to baseline at 24 h (Figure 1C). Adult animals showed no alterations in both proteins and
AQP4 mRNA (Figure 1A–C).
In regard to Cav-1, WB assay showed slight but significant up-regulation at 5 and 24 h post-PNV
administration in neonate group (p < 0.05) while no differences were found between control and
PNV-treated groups in adult rats (Figure 1D,E). Likewise, no differences were observed in mRNA
levels in both ages (Figure 1F). The alterations in AQP4 and Cav-1 in neonate rats were significantly
more prominent than in adult rats.
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Figure 1. Expression of aquaporin (AQP4) and caveolin-1 (Cav-1) in hippocampus of 14-day-old and 
8–10 weeks-old rats after 2, 5, and 24 h of 0.9% saline (control) or Phoneutria nigriventer venom (PNV) 
(1.7 mg/kg) i.p injection. (A,D) Representative Western blots for AQP4, Cav-1, and β-actin expression 
(endogenous control); (B,E) Graphic of Western Blotting for AQP4 and Cav-1. The results were shown 
as percentage of control (100%); (C,F) AQP4 and Cav-1 mRNA levels measured by qPCR were 
normalized by using GADPH as endogenous control. * p < 0.05 compared to the respective control 
(Student’s t-test of data expressed as mean ± SEM); n = 5/time point. 
  
Figure 1. Expression of aquaporin (AQP4) and caveolin-1 (Cav-1) in hippocampus of 14-day-old
and 8–10 weeks-old rats after 2, 5, and 24 h of 0.9% saline (control) or Phoneutria nigriventer venom
(PNV) (1.7 mg/kg) i.p injection. (A,D) Representative Western blots for AQP4, Cav-1, and β-actin
expression (endogenous control); (B,E) Graphic of Western Blotting for AQP4 and Cav-1. The results
were shown as percentage of control (100%); (C,F) AQP4 and Cav-1 mRNA levels measured by qPCR
were normalized by using GADPH as endogenous control. * p < 0.05 compared to the respective control
(Student’s t-test of data expressed as mean ± SE ); n = 5/time point.
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2.2. Immunohistochemistry (IHC)
IHC assays were used to determine possible variability in the level of AQP4 and Cav-1 per
sub-field of hippocampus. IHC adds new information about differential regional alterations in addition
to provide information about location and cellular distribution of the proteins.
AQP4 immunoreactivity was weak in the hippocampi of controls (Figure 2A), suggesting that
the brain water transport is at the physiological level. In PNV-treated samples, the water metabolism
changed depending on the time-course post-envenoming. Figure 2B is illustrative of AQP4 in an adult
animal 5 h post administration of PNV where the protein was upregulated; in this case, the expression
was found mainly in thin astrocytes processes spread all over hippocampal regions and especially
around the capillaries wall. Figure 2C illustrates the Cav-1 immunoreactivity in the endothelium of
hippocampal capillaries in control animals. Figure 2D shows Cav-1 up-regulation in a PNV-treated
adult animal both by stronger reactivity as well as by increased number of labeled capillaries and
perikarya of pyramidal neurons. In addition, the rats administered PNV showed perivascular edema
(Figure 2B,D), likely as a result of swollen astrocytic perivascular end-feet, while no such event is
found in saline-administered animals (Figure 2C). The findings suggest alteration of water metabolism
and BBB permeation disturbance.
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Figure 2. Illustrative immunohistochemical localization of aquaporin (AQP4) and caveolin-1 (Cav-1)
in an adult animal administered saline (A,C) or Phoneutria nigriventer venom (PNV) (B,D) in CA3.
(A,C) The AQP4 and Cav-1 physiologic expression in controls; and (B,D) PNV-induced up-regulated
AQP4 and Cav-1, respectively. Arrowhead: vessel labeling. Arrow: perivascular edema formation in
hippocampus capillaries of PNV-administered animals. Asterisk: neuronal labeling. Scale Bar: 100 µm
for (A,B) and 50 µm for (C,D).
2.3. AQP4
CA1: In CA1 region of PNV-administered neonate rats, AQP4 expression was episodically
down-regulated at 2 h after envenomation (140%, p < 0.05), a period marked by severe toxic
manifestation of animals; then returned to basal levels at 5 h, when animals started showing signs
of recuperation; and increased again at 24 h (108%, p < 0.01), a period at which animals show no
visible sign of intoxication. In adult animals, no significant alterations were detected in all time points
assessed, most likely due to individual variability (large SEM bars) (Figure 3A).
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(Figure 3B). Figure 3 shows the time-course quantification of the density of pixels after selection
by color segmentation of proteins labeling. The data were expressed as percentage of AQP4-labeled
astrocytic processes, and Cav-1-labeled endothelia in CA1, CA2 and CA3 sub-fields of hippocampi in
saline- (control) and PNV-treated rats.
CA3: In CA3 region, a 58% down-regulation of AQP4 at 2 h (p < 0.05) followed by return to
baseline (5 h) and a non-significant increase at 24 h. In contrast, in adults, none of the time-points post
envenoming showed alterations in comparison to control group (Figure 3C).
The measurement of pixels’ density shows that basal AQP4 immunoreactivity in P14 rats was
higher in the order CA3 > CA1 > CA2; PNV exposure altered the immunoreactivity grade seen in
controls. In PNV-treated rats, CA1 was the subfield where downregulation (2 h) and upregulation
(24 h) of the protein were highest. At 2 h time after envenomation, when toxic condition of animals
was worst, the expression of AQP4 in P14 was significantly changed in all subfields CA1, CA2 and
CA3. At 24 h after PNV, AQP4 expression had returned to control level or was upregulated.
2.4. Cav-1
Expressional changes were evident in all three hippocampal sub-fields of neonate and adult rats
in response to PNV intra peritoneal exposure. Nevertheless, the proportion of up-regulation was lower
in adults than in neonate P14 rats. Significant increases in Cav-1 expression in P14 vs. adult rats per
time-course/region were: at 2 h (124% vs. 81% for CA1; 128% vs. 57% for CA2; 111% vs. 253% for CA3,
respectively), 5 h (209% vs. 25% for CA1; 118% vs. 60% for CA2; 146% vs. 146% for CA3, respectively)
and 24 h (232% vs. 39% for CA1; 114% vs. 45% for CA2 and 140% vs. 84% for CA3, respectively)
post PNV-injection.
The up-regulation of the transmembrane protein Cav-1 in the endothelium plasma membrane,
in response to PNV is indicative of increased formation of caveolae and endocytosis at the BBB, as well
as is also suggestive of increased cell trafficking and signal transduction mediated by caveolae.
3. Discussion
The main findings from this study are that the sub-lethal dose of the venom of P. nigriventer spider
injected in rats produces neuro-excitotoxic manifestations to the animals (P14 and 8–10 week-old) which
paralleled with disturbances to hippocampal AQP4 and Cav-1, two transporter proteins and specific
markers of astrocytes and endothelial cells, respectively; Second, the intensity and duration of the
toxic manifestations indicate P14 neonate rats more vulnerable to PNV than adults; Third, the intensity
of the toxic manifestations to P14 decreases temporally while inversely the expression of AQP4 and
Cav-1 increases peaking at 24 h when clinically animals appearance do not differ from saline controls;
Forth, histologically the capillaries of P14 and 8–10 week-old rats treated with PNV show perivascular
edema, while controls did not; Fifth, immunohistochemistry reveals that PNV affects CAs sub-fields
of hippocampus at different degrees throughout time-points; Sixth, regional immunohistochemistry
quantification reveals that in P14 rats Cav-1 peaks at 24 h when toxic manifestations are vanished,
whereas, in 8–10 week-old rats, Cav-1 peaks at 2 h when animals present intense toxic signs and
progressively attenuates such increases until 24 h, remaining though significantly above baseline;
Lastly, this study demonstrates that both the alterations provoked by PNV to astroglial AQP4 and
endothelial Cav-1 in the hippocampus are involved in the mechanisms of BBB breakdown induced by
PNV, first reported by Le Sueur and co-workers [8,9]. The unique characteristics of endothelium
and astrocytic end-feet processes as well as the intimacy of both glio-vascular cell components
at the blood–brain interface are the determinants for microenvironment homeostasis and steady
neuronal function. Toxicological conditions of animals and disturbance of AQP4 and Cav-1 proteins
in animals, mainly P14, treated with sub-lethal dose of PNV indicate that homeostasis was no longer
working properly.
AQP4 and Cav-1 upregulation has been associated to BBB impairment and edema formation
and/or resolution, neuron excitability, endocytosis and neuroinflammation [20,26,28–31].
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The venom of P. nigriventer causes BBB breakdown, swelling of perivascular astrocytes and
extravasation of fluid into the brain extracellular spaces indicating edema formation and BBB
impairment in cerebellum and hippocampus [8,10,32]. PNV also activates neurons, and induces
expression of GFAP, S100 and pro-inflammatory cytokines in astrocytes of the cerebellum and
hippocampus with evidences of nitric oxide (NO) derived from neuronal and endothelial nitric
oxide synthase (nNOS, eNOS, respectively) mediation [33–35].
The present study shows through different assays that two transporter proteins, AQP4 and Cav-1,
undergo changes in the hippocampus of rats after PNV envenomation. Moreover, hippocampal
microvasculature of PNV-treated rats shows perivascular edema, likely a reflex of swollen perivascular
astrocytic end-feet. The findings match with previous studies using same experimental design and
animal model that have shown that PNV induces up-regulations of AQP4 [12] and Cav-1 [13] in the
cerebellum. Thus, likewise in the cerebellum, this study reveals that both the metabolism of water and
the endocytosis and trafficking via fluid-phase transcytosis is age- and region-relatedly altered.
The AQP4 immunoreactivity was found in astrocytes processes throughout the hippocampal
parenchyma and more markedly at the capillary wall surroundings. In addition, the Cav-1
immunoreactivity was found delineating finely the endothelium of the hippocampal capillaries.
The findings conforms to the AQP4 expression, especially at the end-feet membrane specialized
domains of perivascular astrocytes, and in close contact with blood vessels endothelium [16,36].
Cav-1 is a typical endothelial protein, representing 95% of the vesicles in endothelial membrane [37].
The isoform α of Cav-1 is ubiquitously a marker of the protein in the brain [25]. Cav-1 is the main
structural protein of caveolae, a vesicle-shaped specialized lipid-raft domain of endothelium plasma
membrane rich in cholesterol and glycosphingolipids [38], signaling Src kinase [39] and eNOS;
the increased expression of Cav-1 has been associated with increased formation of caveolae along
the endothelial plasma membrane, increased endocytosis and transcytosis and destabilization of BBB
permeability, which collectively contribute to vasogenic edema [13,26,27,40]. In contrast, degradation of
cholesterol by filipin [41] or Cav-1 deletion prevents caveolae-mediated endocytosis and transcytosis,
neuronal death and prevention of vasogenic edema [42].
3.1. AQP4
Comparison of the dynamics of AQP4 expression and its mRNA content at the time frame
selected indicates that P14 rats are more vulnerable to PNV than adults; we hypothesize that regulatory
mechanisms relative to water metabolism have yet not completely settled down in astrocytes at this
age. Indeed, functional properties of these glial cells can change during development and in response
to neuropathological conditions [43]. In astrocytes of the cerebellum and Muller astrocytes of rats’
retina, AQP4 was detectable at the second week of postnatal life, and gains progressive increases
peaking at P56 [44] and P60 [45] of postnatal life. Similar developmental regulation was found in the
expression of AQP4 in the hippocampus of mice, which gradually increases from P9 through P21 and
P42 days of postnatal life [46].
Apart from that, there is increasing evidence that astrocytes from different compartments have
distinct pharmacological and immunocytochemical properties [43]. Studies have shown that in
the mouse hippocampus, the highest expression of AQP4 was detected in astrocytes of CA1, and that
AQP4 and Kir4.1 were co-expressed ubiquitously in nearly all CA1 astrocytes [46]. The authors
identified CA1subfield as potential site of astrocytic K+ and H2O regulation, a critical issue in various
brain diseases.
Such finding correlates with our immunohistochemistry quantification of AQP4 reactivity in
P14 hippocampal astrocytes of rats injected with PNV. Herein, the CA1 was the subfield with major
downregulation of AQP4 in response to PNV (140% in CA1 vs. 58% in CA3 at 2 h), and also the subfield
with major upregulation (108%/24 h in CA1 vs. 52%/2 h in CA2). Astrocytes are key protagonists
to maintain brain homeostasis, which involves the reuptake of both extracellular K+ and excitatory
amino acids and Ca2+ balance after neuronal activity. PNV contains neurotoxins that activate or delay
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inactivation of Na+ and block Ca2+ and K+ channels and interfere in glutamate handling (see [6] for
review). Further studies are necessary to determine the potential role of each subfield in the regulation
of water metabolism. However, based on report by Hsu and co-workers [46] and on our findings
we do not discard the possibility of CA1 as potential site of K+ buffering and water regulation in the
hippocampus. Another interesting issue is to investigate whether the blockade of K+ channels by
PNV has also cell and sub-field specificity, which could be related to differential changes in AQP4
expression. The presence of perivascular edema is indication of BBB breakdown and substantiates
our suggestion that changes in expression of both AQP4 and protein transcripts reflects disturbance
in water balance in the hippocampus. The present results indicate PNV as useful tool in the study of
diverse diseases related with brain edema and excitability.
3.2. Cav-1
The different degrees of up-regulation of Cav-1 at the time frame examined implies a changeable
caveolae dynamics wherein the assembly/disassembly cycles are transformed in mechanical
tension over the endothelial membrane, induces shear stress and consequent interference in
hemodynamics [47,48]. The Cav-1 protein from caveolae, apart from its role in transporter mechanisms,
is more recently implicated in sensing mechanical forces underwent by endothelial membrane,
formation and stabilization of synapses, intercellular communication and signal transduction,
always involving calcium signals [24,48,49]. In this study, the Cav-1 immunoreactivity of pyramidal
neurons of CA hippocampal subfields is documental for the role of the protein also in neuronal
cells function; PNV seemed to enhance the protein labeling (compare the intensity of Cav-1
labeling of pyramidal neurons pictured in Figure 3C (control) and Figure 3D (PNV-treated)).
In hippocampal neurons, there is indication that induction of Cav-1 is triggered through glutamate
exposure, apparently through kainate and AMPA-type receptors [50], receptors that are involved in
hypernociception caused by PNV [6,7,51,52].
In the endothelium, Cav-1 and eNOS share same caveolae’s membrane micro-domain;
Cav-1 negatively regulates eNOS [53]. In the present study, the rise in the expression of Cav-1 (WB
and IHC data) promoted by PNV suggests eNOS inhibition and poor availability of oxide nitric (NO)
and thus endothelium dysfunction. Recent study of our group has shown that PNV proper reduces
availability of NO by leading to eNOS uncoupling [35]; at early periods following envenomation
when toxic manifestation is severe, there is monomerization of eNOS and incapacity of the enzyme to
produce NO, leading to superoxide production and endothelial/vascular BBB dysfunction [54].
Taken together, these data indicate that the two transporter proteins, AQP4 and Cav-1, are targets
of PNV thus revealing their participation in the mechanism involved in the BBB breakdown in the
hippocampus’s capillaries. Considering the preponderance of PNV effects in P14 compared with
8–10 week-old rats we suggest the existence of differences in regulatory mechanisms related to AQP4
and Cav-1/caveolae system. Considering the astrocyte-endothelial intimate physical and functional
interactions and permeability of the BBB [55], we hypothesize that age-related modulations might
be linked to changes in functional properties of astrocytes during post-natal development [43] with
implications to the endothelium Cav-1/caveolae system. The age-related differences here seen could
have role in the higher severity of accidents victimizing children than adults. Neonates are known to
be more susceptible to pathological conditions of the brain than adults [56].
4. Materials and Methods
4.1. Venom and Animals
The lyophilized venom of P. nigriventer spider was kindly donated by Evanguedes Kalapothakis
from Department of General Biology, Institute of Biological Sciences, Federal University of Minas
Gerais (UFMG), Belo Horizonte, MG, Brazil and maintained in −20 ◦C until the moment used.
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Male Wistar rats (Rattus norvegicus) of two ages, 14 days (P14, neonate group) and 8–10 weeks
(8–10 weeks, adult group), were obtained from the Animal House Center Service (CEMIB) at Unicamp,
Campinas, SP, Brazil. The animals were kept in room temperature with food and water ad libitum and
12/12 h cycles of day/night.
The study was approved by the institution’s Committee for Ethics in Animal Use
(CEUA-UNICAMP, protocols 2405-1 and 2411-1) which follows the Brazilian Society for Laboratory
Animal Science (SBCAL) guidelines.
4.2. Envenoming Procedure
The experiments consist of applying an intraperitoneal (i.p.) and sublethal injection of PNV
(1.7 mg/kg) diluted in sterile saline (0.5 mg/µL) according to the weight of the animal. The 1.7 mg/kg
dose was the one that better reproduced the sub-lethal signs of envenoming [8]. Three times
points related to grade of toxic manifestation after venom exposure were chosen: 2 h (intense
envenoming signs); 5 h (signs of recovery from toxic manifestation); and 24 h (absence of clinical
neurotoxic manifestation). There were in total n = 5 animals per hour/technique (total n = 45 per age).
Pared controls received the same volume of the vehicle (0.9% saline) (n = 45 per age/technique/hour).
The sacrifice procedures were described below at each techniques section.
4.3. IHC
The animals were euthanized with anesthetics overdose (3:1 mixture of ketamine chloride
(Dopalen®, 100 mg/kg body weight) and xylazine chloride (Anazedan®, 10 mg/kg body weight,
both from Fortvale, Valinhos, SP, Brazil) and perfused through the left ventricle with 150 mL of
physiological saline followed by 250 mL of 4% paraformaldehyde in 0.1 M phosphate-buffered saline
(PBS), pH 7.4. Then, the hindbrain was immediately removed, post-fixed in the same fixative overnight,
dehydrated in a graded ethanol series, cleared in xylene and embedded in Paraplast® (Sigma-Aldrich,
St. Louis, MO, USA). The immunohistochemistry was performed in 5 µm thick sections [11]. Briefly,
after dewaxed, dehydration and water rinsing, the endogenous peroxidase was blocked and antigen
retrieval was performed. Then, the sections were incubated overnight with primaries antibodies for
anti-rabbit AQP4 (1:100, Sigma-Aldrich) and Cav-1 isoform α (1:200, SC-894, Santa Cruz, CA, USA).
The HRP enzyme (Kit Envision, Dako, Agilent Technologies Company, Glostrup, Denmark) was used
as secondary antibody and DAB (Dako Cytomation, CA, USA) as a chromogenic solution. The slides
were counterstained with Harris Hematoxylin and mounted in Canada balsam. Images were captured
with a photomicroscope Olympus BX51 (Olympus Corporation, Tokyo, Japan). One percent BSA was
used as substitute for primaries antibodies as negative control of the reaction.
IHC Analysis
In order to quantify alterations in AQP4 and Cav-1 expression, immunolabeling of proteins was
measured using the GIMP 2.6.4 (GNU Image Manipulation Program software, CNET Networks, Inc.,
Washington, PA, USA) that converts the digitized images to grayscale images (black and white) after
color selection [57]. Digitized images were taken using a 40× objective using the same aperture and
illumination parameters for all. Two random fields of each region of hippocampus (CA1, CA2, CA3)
for each animal (n = 5/per time/age), totaling 10 images per region per treatment (PNV and 0.9%
saline), were selected. Figure 4 illustrates immunoreactivity of AQP4 and Cav-1 in hippocampal CA3
sub-field and corresponding image after color segmentation in order to transform it in density of pixels.
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Figure 4. Illustrative image analysis using 2.6.4 GIMP software: (A,B) CA3 region of neonate
rat 2 h post-PNV labeled with aquaporin-4 (AQP4) and caveolin-1 (Cav-1) antibody (brown)
and counterstained with Harris Hematoxylin; and (C,D) segmentation by color of the primary
antibody reactivity analyzed by 2.6.4 GIMP software for further quantification of density of pixels.
(A,B) The widespread labeling refers to labeling of astrocytic distal processes; arrowhead shows
endothelial labeling; and (C,D) labeling of Cav-1 in capillaries endothelium. Scale bars: 50 µm.
4.4. qPCR
After the animals were submitted to CO2 chamber, heads were cut off and the brains rapidly
removed and dissected. The hippocampi were homogenate using Trizol reagent (Life Technologies,
Gaithersburg, MD, USA), RNA of hippocampus was extracted according to the manufacturer’s
recommendations. Standard reverse-transcription PCR was performed using total RNA as described
previously [58]. Intron-skipping primers (TaqMan® Universal Master Mix) for AQP4 (catalogue
number: Rn00563196_m1) and Cav-1 (catalogue number: Rn00755834_m1) were obtained from Applied
Biosystems (Carlsbad, CA, USA). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primer
(Applied Biosystems) was used as control. qPCR analysis of gene expression was performed in an ABI
Prism 7500 sequence detection system (Applied Biosystems). The optimal concentrations of cDNA and
primers, as well as the maximum efficiency of amplification, were obtained through five-point, two-fold
dilution curve analysis for each gene. Each PCR contained 25 ng of reverse-transcribed RNA, 200 nM
of each specific primer, SYBR SAFE PCR master mix, RNase free and water to complete a final volume
of 20 µL. Real-time data were analyzed using the Sequence Detector System 1.7 (Applied Biosystems).
4.5. Western Blotting (WB)
The animals were submitted to carbon dioxide (CO2) chamber, heads were cut off in a guillotine,
the hindbrain rapidly removed and stored in liquid nitrogen. The hippocampus were dissected and
homogenized with anti-protease cocktail (10 mM EDTA, 2 mM PMSF, 100 mM NaF, 10 mM sodium
pyrophosphate, 10 mM NaCO4, 10 g of aprotinin/mL and 100 mM Tris, pH 7.4), the contents spun
3000 rpm for 10 min and the supernatant collected and stored at −80 ◦C. The protein concentration
was determined with a kit from Bradford protein assay (Bio-Rad Laboratories Inc., Hercules, CA, USA).
The SDS/PAGE were done with 12% polyacrylamide gel for AQP4 (34 kDa) and Cav-1 (23 kDa).
After electrotransfer to a nitrocellulose membrane, the membranes were incubated with basal solution
(0.1% Tris-buffered saline with 0.05% Tween 20, pH 7.4) plus 5% dry milk for two hours at room
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temperature. Then, the membranes were placed with the primaries antibodies presented in IHC
technique for 5 to 18 h (1:2000 for AQP4 and 1:1500 for Cav-1) followed anti-rabbit secondary
antibody (1:4000, Santa Cruz Biotechnology, Santa Cruz, CA, USA) for two hours. To visualize
the proteins bands a chemiluminescence kit (Super Signal West Pico Chemiluminescent Substrate;
Pierce Biotechnology, Rockford, IL, USA) and an X-ray film (Sigma-Aldrich) was used. The NIH
Image J program 1.41 (developed by Wayne Rasband, NIH, Bethesda, MD, USA) software was used to
performed the densitometry analyses. β-actin (Sigma-Aldrich) immunoblot was done as an internal
control. The results were confirmed in three sets of experiments.
4.6. Statistical Analysis
All data were expressed as the mean ± standard error of the mean (SEM) and were analyzed
using the Graphpad Prism software package (San Diego, CA, USA). The statistical significance among
control and PNV-treated groups was determined by unpaired Student t-test with value of p < 0.05
indicating statistical significance.
5. Conclusions
Taken together, the data indicate that the two transporter proteins, AQP4 and Cav-1, are targets
of PNV thus revealing their participation in the mechanism involved in the BBB breakdown in the
hippocampus’s capillaries. Considering the preponderance of PNV effects in P14 compared with
8–10-week-old rats, we suggest the existence of differences in regulatory mechanisms related to AQP4
and Cav-1/caveolae system. In addition, considering the astrocyte-endothelial intimate physical and
functional interactions and BBB permeability [55], we hypothesize that age-related modulations
here found might be linked to changes in functional properties of astrocytes during post-natal
development [43], with implications to the endothelium Cav-1/caveolae system. The age-related
differences could have role in the higher severity of accidents victimizing children than adults.
Further studies to identify CA1 subfield as a main water regulatory center in the hippocampus
in response to PNV are needed.
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